385 related articles for article (PubMed ID: 28978236)
1. Appropriateness of Dabigatran and Rivaroxaban Prescribing in Qatar: A 5-Year Experience.
Elewa H; El-Makaty H; Ali Z
J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):155-161. PubMed ID: 28978236
[TBL] [Abstract][Full Text] [Related]
2. Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration.
Borne RT; O'Donnell C; Turakhia MP; Varosy PD; Jackevicius CA; Marzec LN; Masoudi FA; Hess PL; Maddox TM; Ho PM
BMC Cardiovasc Disord; 2017 Sep; 17(1):236. PubMed ID: 28865440
[TBL] [Abstract][Full Text] [Related]
3. Volume and Characteristics of Intracerebral Hemorrhage with Direct Oral Anticoagulants in Comparison with Warfarin
.
Adachi T; Hoshino H; Takagi M; Fujioka S;
Cerebrovasc Dis Extra; 2017; 7(1):62-71. PubMed ID: 28376486
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and outcomes in patients with atrial fibrillation receiving direct oral anticoagulants in off-label doses.
Briasoulis A; Gao Y; Inampudi C; Alvarez P; Asleh R; Chrischilles E; Leira EC; Vaughan-Sarrazin M
BMC Cardiovasc Disord; 2020 Feb; 20(1):42. PubMed ID: 32013886
[TBL] [Abstract][Full Text] [Related]
5. Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments.
Eek AK; Øie E; Granas AG
Eur J Clin Pharmacol; 2018 Mar; 74(3):323-330. PubMed ID: 29149366
[TBL] [Abstract][Full Text] [Related]
6. Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?
Alamneh EA; Chalmers L; Bereznicki LR
Am J Cardiovasc Drugs; 2016 Jun; 16(3):183-200. PubMed ID: 26862063
[TBL] [Abstract][Full Text] [Related]
7. Real-world adherence for direct oral anticoagulants in a newly diagnosed atrial fibrillation cohort: does the dosing interval matter?
Pham PN; Brown JD
BMC Cardiovasc Disord; 2019 Mar; 19(1):64. PubMed ID: 30890131
[TBL] [Abstract][Full Text] [Related]
8. Comparative safety and effectiveness of dabigatran vs. rivaroxaban and apixaban in patients with non-valvular atrial fibrillation: a retrospective study from a large healthcare system.
Villines TC; Ahmad A; Petrini M; Tang W; Evans A; Rush T; Thompson D; Oh K; Schwartzman E
Eur Heart J Cardiovasc Pharmacother; 2019 Apr; 5(2):80-90. PubMed ID: 30500885
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Prescribing Practices with Direct Acting Oral Anticoagulant Protocols.
Draper E; Parkhurst B; Carley B; Krueger K; Larson T; Griesbach S
Am J Cardiovasc Drugs; 2017 Dec; 17(6):475-479. PubMed ID: 28887621
[TBL] [Abstract][Full Text] [Related]
10. A systematic review and Bayesian network meta-analysis of risk of intracranial hemorrhage with direct oral anticoagulants.
Wolfe Z; Khan SU; Nasir F; Raghu Subramanian C; Lash B
J Thromb Haemost; 2018 Jul; 16(7):1296-1306. PubMed ID: 29723935
[TBL] [Abstract][Full Text] [Related]
11. Trends in oral anticoagulant use in Qatar: a 5-year experience.
Elewa H; Alhaddad A; Al-Rawi S; Nounou A; Mahmoud H; Singh R
J Thromb Thrombolysis; 2017 Apr; 43(3):411-416. PubMed ID: 28138812
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Efficacy and Safety of Direct Oral Anticoagulants in Japanese Patients-Analysis of Pharmaceuticals and Medical Devices Agency Data.
Terayama Y
J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1171-1181. PubMed ID: 28169097
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.
Yao X; Abraham NS; Sangaralingham LR; Bellolio MF; McBane RD; Shah ND; Noseworthy PA
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27412905
[TBL] [Abstract][Full Text] [Related]
14. Appropriateness of the Direct Oral Anticoagulants Dosing in the Middle East Gulf Region.
Anouassi Z; Atallah B; Alsoud LO; El Nekidy W; Al Mahmeed W; AlJaabari M; Almuti K
J Cardiovasc Pharmacol; 2021 Feb; 77(2):182-188. PubMed ID: 32925474
[TBL] [Abstract][Full Text] [Related]
15. Inappropriate doses of direct oral anticoagulants in real-world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA Registry.
Ruiz Ortiz M; Muñiz J; Raña Míguez P; Roldán I; Marín F; Asunción Esteve-Pastor M; Cequier A; Martínez-Sellés M; Bertomeu V; Anguita M;
Europace; 2018 Oct; 20(10):1577-1583. PubMed ID: 29186393
[TBL] [Abstract][Full Text] [Related]
16. Body Mass Index Influence on the Clinical Outcomes for Nonvalvular Atrial Fibrillation Patients Admitted to a Hospital Treated with Direct Oral Anticoagulants: A Retrospective Cohort Study.
Li X; Zuo C; Ji Q; Xue Y; Wang Z; Lv Q
Drug Des Devel Ther; 2021; 15():1931-1943. PubMed ID: 33986592
[TBL] [Abstract][Full Text] [Related]
17. Identification of risk factors for inappropriate and suboptimal initiation of direct oral anticoagulants.
Howard M; Lipshutz A; Roess B; Hawes E; Deyo Z; Burkhart JI; Moll S; Shilliday BB
J Thromb Thrombolysis; 2017 Feb; 43(2):149-156. PubMed ID: 27757787
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
Coleman CI; Peacock WF; Bunz TJ; Alberts MJ
Stroke; 2017 Aug; 48(8):2142-2149. PubMed ID: 28655814
[TBL] [Abstract][Full Text] [Related]
19. The Comparison of Inappropriate-Low-Doses Use among 4 Direct Oral Anticoagulants in Patients with Atrial Fibrillation: From the Database of a Single-Center Registry.
Sato T; Aizawa Y; Fuse K; Fujita S; Ikeda Y; Kitazawa H; Takahashi M; Okabe M
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3280-3288. PubMed ID: 30121155
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy.
Barra ME; Fanikos J; Connors JM; Sylvester KW; Piazza G; Goldhaber SZ
Am J Med; 2016 Nov; 129(11):1198-1204. PubMed ID: 27341955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]